NCT06619912View on ClinicalTrials.gov

Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

686

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

March 30, 2027

Conditions
Postoperative DeliriumPreoperative Sleep Disorder
Interventions
DRUG

Dexmedetomidine nasal spray

Participants will be randomised to receive either dexmedetomidine or saline nasal spray (1.5ug/kg, ideal body weight) at the night before surgery and 30 minutes before induction.

Trial Locations (1)

710032

RECRUITING

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER